Abstract
Empirical evidence on the epidemiological characteristics of the emerged SARS‐CoV‐2 variants could shed light on the transmission potential of the virus and strategic outbreak control planning. In this study, by using contact tracing data collected during an Omicron‐predominant epidemic phase in Hong Kong, we estimated the mean serial interval of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants at 2.8 days (95% credible interval [CrI]: 1.5, 6.7), 2.7 days (95% CrI: 2.1, 3.6), and 4.4 days (95% CrI: 2.6, 7.5), respectively, with adjustment for right truncation and sampling bias. The short serial interval for the current circulating variant indicated that outbreak mitigations through contact tracing and case isolation would be quite challenging.
Keywords: COVID‐19, disease transmission, Hong Kong, SARS‐CoV‐2 omicron variant, serial infection interval
1. INTRODUCTION
As one of the genetic variants of concern (VOCs) of SARS‐CoV‐2 declared by the World Health Organization (WHO), the Omicron (B.1.1.529) variants spread at a rapid rate with novel genetic mutations persistently reported globally. Two emerging Omicron subvariants that were first detected in South Africa in January 2022, that is, BA.4 and BA.5, have risen public health concerns due to their transmission advantages against previous circulating variants. 1 , 2 Another subvariant of the Omicron lineage, BA.2.12.1 variants, emerged in the United States in February 2022 and also outcompeted the Omicron BA.2 locally, though it was subsequently replaced by BA.4 and BA.5. 3
Current immunologic knowledge indicated that BA.4 and BA.5 variants had stronger resistance to the antibody elicited by vaccination or by previous infections of BA.1 or BA.2. 4 However, little is known about the epidemiological characteristics of these variants, in particular, the serial interval (SI), which is defined as the time interval between the symptom onset date of primary and secondary cases. The knowledge of the distribution of SI is essential for informing the responsiveness of the control measures (i.e., contact tracing) and reliable estimation of key biological parameters. In this study, we used contact tracing data in Hong Kong to estimate the SI distributions of Omicron BA.4, BA.5, and BA.2.12.1 variants.
2. METHOD
2.1. Data
We collected line‐list contact tracing data of each individual SARS‐CoV‐2 infection reported from May 1 to July 17, 2022, from the Centre for Health Protection of the Department of Health in Hong Kong. We extracted the information of symptom onset date, case confirmation date, hospital admission date, contact tracing history, vaccine history, and genotype of the SARS‐CoV‐2 infected. To obtain SI observations, we constructed the infector–infectee transmission pairs of reported cases based on the contact tracing history.
2.2. Identification of transmission pairs
Based on the contact tracing history for cases with known symptom onset dates provided by the Centre for Health Protection of Hong Kong, we first identified case clusters, comprising a group of epidemiologically linked cases. Case clusters could involve one or multiple generations. Within the case clusters, cases marked by “imported” (cases that acquired infection outside Hong Kong based on the symptom onset dates and recent travel histories) or “local” (cases acquired infection locally and without recent travel history) were considered as the index cases (infector) of the cases in the secondary generation (marked by “close contact with local” or “close contact with imported”). For later generations where cases were all marked by “close contact with local” or “close contact with imported,” the infectors were determined only by the reported contact tracing history; that is, cases first exposed to the index cases or previous generations were the infector of the current generation. Infector–infectee transmission pairs were then resolved from case clusters. Infectees with two or more possible infectors were excluded from the analysis. Asymptomatic cases and unlink cases (i.e., cases that were associated with certain contact settings but were not epidemiologically linked with others and cases that were recorded linking to multiple infectors) were excluded from the analysis. We also excluded the pairs with SIs exceeding 15 days or below −5 days to ensure biologically plausible SI distributions. 5
2.3. Statistical analysis
We denoted as the SI for the th transmission pair, which was defined as the time interval between the illness onset date of the infector and that of his/her associated infectee. We assumed the SI of the BA.4, BA.5, and BA.2.12.1 followed a gamma distribution, denoted by . For observed negative SI (pre‐symptomatic transmission), we added a shift in . During the early phase of an outbreak, shorter SI is more likely to be identified due to the exponential growth of case numbers. 6 We corrected such sampling bias in by adjusting the exponential growth with rates r of 0.04, 0.02, and 0.04 per capita per day (estimated from the epidemic curve) for BA.2.12.1, BA.4, and BA.5, respectively. We also conducted sensitivity analysis using different exponential growth rates (from 0.01 to 0.06). The sampling‐bias‐adjusted distribution function is given by 7 :
Additionally, we also considered the right truncation of the time interval 8 ; that is, the SI generated by each infector is truncated due to timely case isolation. Thus, the truncation‐adjusted distribution function is given by
Here, the is the cumulative density function of . The is the confirmation delay, that is, the time interval between the symptom onset and isolation of the infector for the th transmission pair. We used the hospital admission date as a surrogate of the isolation date. For cases without known admission dates, we used the case confirmation date instead. For a total of transmission pairs identified for a certain type of Omicron subvariant, the likelihood function is given by
2.4. Parameter estimations
The parameters of gamma distribution were estimated by using the Metropolis–Hastings algorithm, which is a Markov chain Monte Carlo (MCMC) method, with noninformative prior distributions. The marginal posterior distribution was obtained from 100,000 iterations, among which the first 40,000 samples were discarded as for burn‐in. The convergence of each MCMC chain was checked by using the trace plot and Gelman–Rubin–Brooks convergence diagnostic. The median and the 95% credible interval (CrI) of the mean, standard deviation, median, and 95th percentile of the SI distributions were computed from the high‐density region of the 60,000 posterior samples.
3. RESULT AND DISCUSSION
The process of data collection was shown in Figure 1. A total of 90,126 confirmed cases were reported during the study period, of which 8538 went through contact tracings. Among the 8538 traced cases, 1366 cases had known genotype information, within which 846 cases were found infected by the Omicron BA.4/BA.5/BA.2.12.1 variants. After excluding asymptomatic cases and unlink cases, we identified a total of 104 transmission pairs including 8, 51, and 45 pairs with BA.4, BA.5, and BA.2.12.1 infections, respectively (Figures 1 and 2). Of all identified transmission pairs, there were 8, 43, and 40 received at least two doses of the COVID‐19 vaccine, respectively. The demographic characteristics of cases and contact settings where infection occurred between transmission pairs were not statistically different between the study samples and overall cases during the study period (Tables S1 and S2). The empirical mean SI estimates without adjusting for truncation and sampling bias were estimated at 2.1 days (95% CrI: 1.3, 3.6), 2.4 days (95% CrI: 1.9, 2.9), and 2.4 days (95% CrI: 1.8, 3.3) for BA.4, BA.5, and BA.2.12.1, respectively (Table 1 and Figure 3). During an ongoing epidemic, both exponential growth of case numbers and rapid case isolation measures could lead to an underestimation of the SI. 6 , 8 , 9 We thus considered such bias in the analysis and the adjusted estimates approaches the intrinsic distribution of SI. 10 After adjustments, the mean SI estimates were 2.8 days (95% CrI: 1.5, 6.7), 2.7 days (95% CrI: 2.1, 3.6), and 4.4 days (95% CrI: 2.6, 7.5) for BA.4, BA.5, and BA.2.12.1, respectively (Tables 1 and S3 and Figure 3). For BA.4, BA.5, and BA.2.12.1, the estimated 95th percentiles of SI were 7.1, 6.1, and 12.8 days, respectively (Table 1). Moreover, our model appeared to be less sensitive to the exponential growth rate (Table S4).
TABLE 1.
Omicron subvariants | Model adjustment | Mean (95% CrI) | SD (95% CrI) | Median (95% CrI) | 95th percentile (95% CrI) |
---|---|---|---|---|---|
BA.2.12.1 (n = 45) | Without adjustment | 2.4 (1.8, 3.3) | 2.3 (1.7, 3.5) | 1.7 (1.2, 2.3) | 7.1 (5.4, 10.1) |
Adjust for sampling bias | 2.6 (2.0, 3.8) | 2.5 (1.8, 3.9) | 1.9 (1.3, 2.6) | 7.7 (5.6, 11.6) | |
Adjust for sampling bias and right truncation | 4.4 (2.6, 7.5) | 4.3 (2.4, 7.5) | 2.9 (1.7, 4.8) | 12.8 (7.3, 21.7) | |
BA.4 (n = 8) | Without adjustment | 2.1 (1.3, 3.6) | 1.6 (1.0, 3.1) | 1.7 (0.9, 2.9) | 5.2 (3.3, 9.6) |
Adjust for sampling bias | 2.2 (1.3, 3.8) | 1.6 (1.1, 3.6) | 1.7 (1.0, 3.1) | 5.4 (3.4, 9.6) | |
Adjust for sampling bias and right truncation | 2.8 (1.5, 6.7) | 2.1 (1.1, 5.4) | 2.2 (1.1, 5.3) | 7.1 (3.8, 16.9) | |
BA.5 (n = 51) | Without adjustment | 2.4 (1.9, 2.9) | 2.0 (1.6, 2.6) | 2.2 (1.7, 2.7) | 5.5 (4.7, 6.6) |
Adjust for sampling bias | 2.5 (2.0, 3.1) | 1.8 (1.5, 2.3) | 2.3 (1.8, 2.8) | 5.8 (4.9, 7.1) | |
Adjust for sampling bias and right truncation | 2.7 (2.1, 3.6) | 2.5 (1.9, 3.2) | 2.5 (1.9, 3.2) | 6.1 (5.0, 8.9) |
Abbreviation: CrI, credible interval.
The empirical mean SI estimate of BA.2.12.1 variants was largely in line with previous estimates of 2.7 days for BA.2 variants in Hong Kong 11 but relatively low than 3.3 days in United Kingdom. 12 Because the SI of Omicron BA.4 and BA.5 variants appeared shorter than those of BA.2 and other preceding strains (e.g., Delta and Alpha), 13 , 14 this might contribute to explaining the selection advantages of BA.4 and BA.5 in many countries globally. 1 As a recent study indicated that vaccination for both case‐patients of a transmission pair may potentially increase the SI, 5 it is possible that the intrinsic SI for BA.4 and BA.5 may be smaller than what we obtained given that majority of included transmission pairs were fully vaccinated (i.e., two‐dose vaccination).
Our study had some limitations. First, our estimations relied on contact tracing data, and thus, any recall bias from the reported cases and/or case under‐ascertainment would affect the accuracy of the identified transmission pairs, which may bias our results. Second, contact tracing of cases was limited during the surge of cases, and the local surveillance systems could only trace a relatively small proportion of cases, thus, the sample size of transmission pairs was relatively small. In addition, selection bias on the transmission pairs could occur during a growth phase of cases as infectors that had more recent symptom onset were more likely to be sampled for an infectee. 6 Nonetheless, we corrected for such bias in our statistical models, and we believe our results were less subjected to this bias. Last, because our sample sizes were small, we could not elucidate the effect of demographic factors (i.e., age and sex), types of contact setting, and vaccinations on the SI distribution of the Omicron subvariants.
In conclusion, our analysis showed a shorter SI for the novel SARS‐CoV‐2 Omicron subvariants during the current BA.5 global predominance phases. Thus, outbreak mitigations that relied on contact tracing and case isolations were challenging. We highlighted the need to continuously monitor the epidemiological feature of emerging COVID‐19 variants for a better understanding of their transmission potential for planning targeted control strategies in time.
AUTHOR CONTRIBUTIONS
Conceptualization: Zihao Guo, Shi Zhao, and Ka Chun Chong. Data curation: Carrie Ho Kwan Yam and Tsz Yu Chow. Methodology: Zihao Guo and Shi Zhao. Formal analysis: Zihao Guo. Visualization: Zihao Guo. Validation: Shi Zhao and Ka Chun Chong. Writing—original draft: Zihao Guo. Writing—review & editing: Zihao Guo, Shi Zhao, Eng Kiong Yeoh, Ka Chun Chong, Conglu Li, and Xiaoting Jiang. Resources: Ka Chun Chong and Eng Kiong Yeoh. Project administration: Ka Chun Chong and Eng Kiong Yeoh. Supervision: Ka Chun Chong and Eng Kiong Yeoh.
CONFLICT OF INTEREST STATEMENT
All authors declared no conflict of interest.
PEER REVIEW
The peer review history for this article is available at https://publons.com/publon/10.1111/irv.13105.
Supporting information
ACKNOWLEDGMENTS
This work was supported by Health and Medical Research Fund (grant numbers COVID190105, COVID19F03, and INF‐CUHK‐1), Collaborative Research Fund of University Grants Committee (grant number C4139‐20G), National Natural Science Foundation of China (NSFC) (71974165), and Group Research Scheme from The Chinese University of Hong Kong. The Centre for Health Systems and Policy Research funded by the Tung Foundation is acknowledged for the support throughout the conduct of this study.
Guo Z, Zhao S, Yam CHK, et al. Estimating the serial intervals of SARS‐CoV‐2 Omicron BA.4, BA.5, and BA.2.12.1 variants in Hong Kong. Influenza Other Respi Viruses. 2023;17(2):e13105. doi: 10.1111/irv.13105
Zihao Guo and Shi Zhao contributed equally to this article.
Funding information
This work was supported by Health and Medical Research Fund (grant numbers COVID190105, COVID19F03, and INF‐CUHK‐1), Collaborative Research Fund of University Grants Committee (grant number C4139‐20G), National Natural Science Foundation of China (NSFC) (71974165), and Group Research Scheme from The Chinese University of Hong Kong.
DATA AVAILABILITY STATEMENT
The dataset is not public‐available because the data are owned by third parties. Access to these data and permission could be inquired through the Hospital Authority and Department of Health, Hong Kong SAR Government.
REFERENCES
- 1. Weekly epidemiological update on COVID‐19‐26 October 2022. Who.int. Accessed October 26, 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---26-october-2022
- 2. Li A, Yung A, Tran C, Boulet M. SARS‐CoV‐2 omicron BA.5: riding the seventh wave in Central Canada. Influenza Other Respi Viruses. 2022;16(6):1202‐1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. CDC . COVID data tracker. Centers for Disease Control and Prevention; 2020. Accessed October 26, 2022. https://covid.cdc.gov/covid-data-tracker/
- 4. Hachmann NP, Miller J, Collier ARY, et al. Neutralization escape by SARS‐CoV‐2 omicron subvariants BA.2.12.1, BA.4, and BA.5. N Engl J Med. 2022;387(1):86‐88. doi: 10.1056/NEJMc2206576 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Kremer C, Braeye T, Proesmans K, André E, Torneri A, Hens N. Serial intervals for SARS‐CoV‐2 omicron and Delta variants, Belgium, November 19‐December 31, 2021. Emerg Infect Dis. 2022;28(8):1699‐1702. doi: 10.3201/eid2808.220220 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Park SW, Sun K, Champredon D, et al. Forward‐looking serial intervals correctly link epidemic growth to reproduction numbers. Proc Natl Acad Sci U S a. 2021;118(2):e2011548118. doi: 10.1073/pnas.2011548118 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Lau YC, Tsang TK, Kennedy‐Shaffer L, et al. Joint estimation of generation time and incubation period for coronavirus disease 2019. J Infect Dis. 2021;224(10):1664‐1671. doi: 10.1093/infdis/jiab424 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Zhao S, Gao D, Zhuang Z, et al. Estimating the serial interval of the novel coronavirus disease (COVID‐19): a statistical analysis using the public data in Hong Kong from January 16 to February 15, 2020. Front Physiol. 2020;8:8. doi: 10.3389/fphy.2020.00347 [DOI] [Google Scholar]
- 9. Zhao S, Tang B, Musa SS, et al. Estimating the generation interval and inferring the latent period of COVID‐19 from the contact tracing data. Epidemics. 2021;36(100482):100482. doi: 10.1016/j.epidem.2021.100482 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Champredon D, Dushoff J. Intrinsic and realized generation intervals in infectious‐disease transmission. Proc Biol Sci. 2015;282(1821):20152026. doi: 10.1098/rspb.2015.2026 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Mefsin YM, Chen D, Bond HS, et al. Epidemiology of infections with SARS‐CoV‐2 omicron BA.2 variant, Hong Kong, January‐march 2022. Emerg Infect Dis. 2022;28(9):1856‐1858. doi: 10.3201/eid2809.220613 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. SARS‐CoV‐2 variants of concern and variants under investigation in England. Govuk; 2022. Accessed October 26, 2022. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1056487/Technical-Briefing-36-22.02.22.pdf
- 13. Ryu S, Kim D, Lim JS, Ali ST, Cowling BJ. Serial interval and transmission dynamics during SARS‐CoV‐2 Delta variant predominance, South Korea. Emerg Infect Dis. 2022;28(2):407‐410. doi: 10.3201/eid2802.211774 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. An der Heiden M, Buchholz U. Serial interval in households infected with SARS‐CoV‐2 variant B.1.1.529 (Omicron) is even shorter compared to Delta. Epidemiol Infect. 2022;150(e165):e165. doi: 10.1017/S0950268822001248 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The dataset is not public‐available because the data are owned by third parties. Access to these data and permission could be inquired through the Hospital Authority and Department of Health, Hong Kong SAR Government.